Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

NCT06033183 is registered in ClinicalTrials.gov with Neolys as lead sponsor.

NCT NCT06033183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06033183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
Lead sponsor
Neolys
Phase
Not applicable
Overall status
Recruiting
Start date
December 2, 2023
Completion date
October 30, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer, radiation toxicity, radiosensitivity